Business UpdateAug 31, 2026, 05:29 PM
Moleculin Biotech Posts Investor Presentation
AI Summary
Moleculin Biotech, Inc. has filed an 8-K report detailing the use of an investor presentation dated August 31, 2026. This presentation is available on the company's website and is being furnished under Regulation FD Disclosure. The filing also includes the investor presentation as an exhibit.
Key Highlights
- Moleculin Biotech, Inc. is using an investor presentation dated August 31, 2026.
- The presentation is posted on the Company's website.
- The information is being furnished under Regulation FD Disclosure.
Price Impact
More from MBRX